Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Carroll

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Biotechniques|September 1, 1995
E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia virusesM W Carroll, B Moss
Virology|December 24, 1997
Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell lineM W Carroll, B Moss
Current Opinion in Biotechnology|November 14, 1997
Poxviruses as expression vectorsM W Carroll, B Moss
Research Quarterly for Exercise and Sport|December 1, 1991
The metabolic cost of two ranges of arm position height with and without hand weights during low impact aerobic danceM W Carroll, R M Otto, J Wygand
Current Protocols in Molecular Biology|February 12, 2008
Generation of recombinant vaccinia virusesP L Earl, B Moss, L S Wyatt, et al.
Current Protocols in Protein Science|April 23, 2008
Generation of recombinant vaccinia virusesP L Earl, B Moss, L S Wyatt, et al.
Current Protocols in Protein Science|April 23, 2008
Preparation of cell cultures and vaccinia virus stocksP L Earl, N Cooper, L S Wyatt, et al.
Current Protocols in Molecular Biology|February 12, 2008
Preparation of cell cultures and vaccinia virus stocksP L Earl, N Cooper, L S Wyatt, et al.
Gene Therapy|March 18, 2005
In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodiesA Lamikanra, K A Myers, N Ferris, et al.
Vaccine|August 1, 1997
Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virusS Yang, M W Carroll, A P Torres-Duarte, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Biotechniques|September 1, 1995
E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia virusesM W Carroll, B Moss
Virology|December 24, 1997
Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell lineM W Carroll, B Moss
Current Opinion in Biotechnology|November 14, 1997
Poxviruses as expression vectorsM W Carroll, B Moss
Research Quarterly for Exercise and Sport|December 1, 1991
The metabolic cost of two ranges of arm position height with and without hand weights during low impact aerobic danceM W Carroll, R M Otto, J Wygand
Current Protocols in Molecular Biology|February 12, 2008
Generation of recombinant vaccinia virusesP L Earl, B Moss, L S Wyatt, et al.
Current Protocols in Protein Science|April 23, 2008
Generation of recombinant vaccinia virusesP L Earl, B Moss, L S Wyatt, et al.
Current Protocols in Protein Science|April 23, 2008
Preparation of cell cultures and vaccinia virus stocksP L Earl, N Cooper, L S Wyatt, et al.
Current Protocols in Molecular Biology|February 12, 2008
Preparation of cell cultures and vaccinia virus stocksP L Earl, N Cooper, L S Wyatt, et al.
Gene Therapy|March 18, 2005
In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodiesA Lamikanra, K A Myers, N Ferris, et al.
Vaccine|August 1, 1997
Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virusS Yang, M W Carroll, A P Torres-Duarte, et al.
Pageof 4